197 related articles for article (PubMed ID: 16193445)
1. [Adequacy of anticoagulant prevention in patients with atrial fibrillation].
García-García J; Calleja-Puerta S; de la Vega-Cerezales V; Benavente-Fernández L; Rodríguez-Rodríguez S; Hernández-Lahoz C
Rev Neurol; 2005 Oct 1-15; 41(7):399-403. PubMed ID: 16193445
[TBL] [Abstract][Full Text] [Related]
2. [Modification of clinical profile of stroke in atrial fibrillation patients. Effect of antithrombotic treatment].
García Escrivà A; López Hernández N; Hernández Lorido R; Oliver Navarrete C; Bustos S; Carneado Ruiz J; Gracia Fleta F; Moltó Jordá JM
Rev Neurol; 2004 Mar 1-15; 38(5):401-5. PubMed ID: 15029514
[TBL] [Abstract][Full Text] [Related]
3. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy.
Hohnloser SH; Pajitnev D; Pogue J; Healey JS; Pfeffer MA; Yusuf S; Connolly SJ;
J Am Coll Cardiol; 2007 Nov; 50(22):2156-61. PubMed ID: 18036454
[TBL] [Abstract][Full Text] [Related]
4. Anticoagulation therapy in atrial fibrillation in combination with acute myocardial infarction influences long-term outcome: a prospective cohort study from the Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA).
Stenestrand U; Lindbäck J; Wallentin L;
Circulation; 2005 Nov; 112(21):3225-31. PubMed ID: 16301355
[TBL] [Abstract][Full Text] [Related]
5. Anticoagulant and antiplatelet therapy for stroke prevention in atrial fibrillation patients in the clinical practice of a single district hospital in Poland.
Bednarski J; Cieszewska E; Strzelecki A; Filipiak KJ
Kardiol Pol; 2013; 71(12):1260-5. PubMed ID: 23990227
[TBL] [Abstract][Full Text] [Related]
6. Pre-admission warfarin use in patients with acute ischemic stroke and atrial fibrillation: The appropriate use and barriers to oral anticoagulant therapy.
Partington SL; Abid S; Teo K; Oczkowski W; O'Donnell MJ
Thromb Res; 2007; 120(5):663-9. PubMed ID: 17434577
[TBL] [Abstract][Full Text] [Related]
7. Outcomes and safety of antithrombotic treatment in patients aged 80 years or older with nonvalvular atrial fibrillation.
Ruiz Ortiz M; Romo E; Mesa D; Delgado M; Ibáñez CL; Anguita M; Castillo JC; Arizón JM; Suárez de Lezo J
Am J Cardiol; 2011 May; 107(10):1489-93. PubMed ID: 21420049
[TBL] [Abstract][Full Text] [Related]
8. Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation.
Nieuwlaat R; Capucci A; Lip GY; Olsson SB; Prins MH; Nieman FH; López-Sendón J; Vardas PE; Aliot E; Santini M; Crijns HJ;
Eur Heart J; 2006 Dec; 27(24):3018-26. PubMed ID: 16731536
[TBL] [Abstract][Full Text] [Related]
9. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
[TBL] [Abstract][Full Text] [Related]
10. Clinical consequences of hospital variation in use of oral anticoagulant therapy after first-time admission for atrial fibrillation.
Hansen ML; Gadsbøll N; Rasmussen S; Gislason GH; Folke F; Andersen SS; Schramm TK; Sørensen R; Fosbøl EL; Abildstrøm SZ; Madsen M; Poulsen HE; Køber L; Torp-Pedersen C
J Intern Med; 2009 Mar; 265(3):335-44. PubMed ID: 19141096
[TBL] [Abstract][Full Text] [Related]
11. Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.
Anderson DR; Gardner MJ; Putnam W; Jassal D; Brownell B; Flowerdew G; Nagpal S; Thompson K; Cox JL
Can J Cardiol; 2005 Mar; 21(3):257-66. PubMed ID: 15776115
[TBL] [Abstract][Full Text] [Related]
12. Underutilization of oral anticoagulant therapy for stroke prevention in elderly patients with heart failure.
Ibrahim SA; Kwoh CK
Am Heart J; 2000 Aug; 140(2):219-20. PubMed ID: 10925333
[TBL] [Abstract][Full Text] [Related]
13. Impact of prestroke oral anticoagulation on severity and outcome of ischemic and hemorrhagic stroke in patients with atrial fibrillation.
Audebert HJ; Schenk B; Schenkel J; Heuschmann PU
Cerebrovasc Dis; 2010; 29(5):476-83. PubMed ID: 20299787
[TBL] [Abstract][Full Text] [Related]
14. Stroke prevention in hospitalized patients with atrial fibrillation: a population-based study.
Nagpal S; Anderson D; Putnam W; Flowerdew G; Gardner M; Cox J
Can J Clin Pharmacol; 2003; 10(4):197-201. PubMed ID: 14712325
[TBL] [Abstract][Full Text] [Related]
15. Stroke prophylaxis in atrial fibrillation: who gets it and who does not? Report from the Stockholm Cohort-study on Atrial Fibrillation (SCAF-study).
Friberg L; Hammar N; Ringh M; Pettersson H; Rosenqvist M
Eur Heart J; 2006 Aug; 27(16):1954-64. PubMed ID: 16847008
[TBL] [Abstract][Full Text] [Related]
16. Use and underuse of oral anticoagulation for stroke prevention in atrial fibrillation: old and new paradigms.
Pisters R; de Vos CB; Nieuwlaat R; Crijns HJ
Semin Thromb Hemost; 2009 Sep; 35(6):554-9. PubMed ID: 19787559
[TBL] [Abstract][Full Text] [Related]
17. Quality of care for atrial fibrillation among patients hospitalized for heart failure.
Piccini JP; Hernandez AF; Zhao X; Patel MR; Lewis WR; Peterson ED; Fonarow GC;
J Am Coll Cardiol; 2009 Sep; 54(14):1280-9. PubMed ID: 19778670
[TBL] [Abstract][Full Text] [Related]
18. Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallel-arm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter.
Connolly SJ; Crijns HJ; Torp-Pedersen C; van Eickels M; Gaudin C; Page RL; Hohnloser SH;
Circulation; 2009 Sep; 120(13):1174-80. PubMed ID: 19752319
[TBL] [Abstract][Full Text] [Related]
19. Newly detected atrial fibrillation and compliance with antithrombotic guidelines.
Glazer NL; Dublin S; Smith NL; French B; Jackson LA; Hrachovec JB; Siscovick DS; Psaty BM; Heckbert SR
Arch Intern Med; 2007 Feb; 167(3):246-52. PubMed ID: 17296879
[TBL] [Abstract][Full Text] [Related]
20. Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.
Flaker GC; Gruber M; Connolly SJ; Goldman S; Chaparro S; Vahanian A; Halinen MO; Horrow J; Halperin JL;
Am Heart J; 2006 Nov; 152(5):967-73. PubMed ID: 17070169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
